UC Health, Blue Shield Extend Contract Deadline, Stave Off Disruption Of Care

UC Health and Blue Shield of California, which are at an impasse over the terms of a new contract that could disrupt health care for thousands of Californians, have extended the deadline for reaching a new agreement from July 9 to Aug. 9. This means the thousands of Californians who get medical care at UC ...

Read More

Blue Shield Of California Cuts Medicare Advantage Broker Commissions

Blue Shield of California is cutting broker commissions for new enrollments into Medicare Advantage PPO plans in Alameda, Orange and San Diego counties, effective July 1. The new policy does not affect commission payments of existing membership, according to a June memo sent to brokers. Several large insurers have cut MA commissions recently, including UnitedHealthcare, Elevance Health ...

Read More

SCOTUS Upholds ACA Preventive Services Task Force In 6-3 Ruling

The Supreme Court upheld a key preventive services task force in a 6-3 ruling issued Friday morning. The high court determined that members of the U.S. Preventive Services Task Force, which makes recommendations for coverage requirements under the Affordable Care Act, are selected within the bounds of the Constitution. In the case, Braidwood Management, an ...

Read More

Prescription Costs A Burden For Two-Thirds Of Americans, Survey Finds

In 2025, nearly 4 in 10 people said they worried about being able to afford their medications, up significantly from 27% in 2024.

Read More

Trump Officials Met With Walmart on Direct-to-Patient Drug Sales

US health officials met with with Walmart Inc., Amazon.com Inc. and other retailers this week as part of an effort to help Americans get their medicines more directly from companies that make them, according to people familiar with the talks. The conversations between the Trump administration and experts from the nascent straight-to-consumer drug industry are ...

Read More

California AG Says 23andme Sale ‘Does Not Comply’ With State Law

Genetic testing company 23andMe’s recent sale to a research institute “does not comply” with California’s landmark genetic privacy law, state Attorney General Rob Bonta’s office said Monday. What happened: Bonta’s office said the terms of 23andMe’s sale, approved Friday by a federal bankruptcy judge, run afoul of the state’s Genetic Information Privacy Act, which requires companies to ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square